456 National Trends, Complications, and Reoperation Rates in Surgical Management of Intramedullary Spinal Cord Tumors: A NIS-Based Analysis

View at publisher Summarise with VIRAT
Authors: Harendra Kumar, FNU Teena
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Intramedullary spinal cord tumors (IMSCTs) are rare but surgically complex neoplasms often requiring meticulous resection under neuromonitoring. Most existing data are limited to small institutional series. This study aims to provide a comprehensive national perspective on IMSCT surgery, including complication profiles and early reoperation rates, to guide surgical decision-making and perioperative planning. METHODS: We used the National inpatient Sample (NIS) from 2016–2020 to identify adult patients (≥18 years) undergoing laminectomy or spinal cord tumor excision (ICD-10-PCS: 00B10ZZ, 0SB00ZZ) with a diagnosis of intramedullary neoplasm (ICD-10-CM: D33.4, C72.0). Trends in surgical volume, complications (neurological, respiratory, urinary, thromboembolic), length of stay (LOS), discharge disposition, and 30-day readmission/reoperation were assessed. Multivariable logistic regression identified predictors of in-hospital complications and non-routine discharge, adjusting for age, sex, tumor location, comorbidities, hospital teaching status, and surgical approach. RESULTS: A total of 2,584 IMSCT surgical cases were identified. The annual volume remained stable over the 5-year period. Overall, 27.4% of patients experienced at least one perioperative complication, most commonly urinary retention (11.8%) and motor/sensory deficits (9.5%). The in-hospital mortality rate was 1.1%, and mean LOS was 7.6 days. Non-routine discharge occurred in 39.2% of cases. Early reoperation within the index admission occurred in 6.4%, most often due to hematoma evacuation or CSF leak repair. In adjusted models, age ≥70 (OR 1.92; 95% CI: 1.51–2.43), cervical tumor location (OR 1.36; 95% CI: 1.12–1.64), and non-teaching hospital status (OR 1.44; 95% CI: 1.18–1.75) were associated with higher odds of complications and prolonged LOS. High-volume centers had significantly lower complication and reoperation rates. CONCLUSIONS: Surgical management of IMSCTs carries substantial risk of neurologic and urinary complications, prolonged hospitalization, and non-routine discharge. Older age, cervical tumor location, and treatment at low-volume or non-teaching centers are key predictors of adverse outcomes. These findings underscore the need for centralized care and perioperative risk stratification to improve outcomes for patients undergoing IMSCT resection.

Fields of Study & Subjects

Glioma Diagnosis and Treatment Meningioma and schwannoma management Management of metastatic bone disease

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
133–133
Publication date
26 March 2026
Language
EN